FDA Drug Shortages

THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Tirzepatide Injection
Status: Currently in Shortage
»Date first posted: 12/15/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Co. (Revised 10/12/2023)

Company Contact Information:
800-545-5979

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Mounjaro, Injection, 5 mg/.5 mL (NDC 0002-1495-80)	Available
Mounjaro, Injection, 10 mg/.5 mL (NDC 0002-1471-80)	Available
Mounjaro, Injection, 2.5 mg/.5 mL (NDC 0002-1506-80)	Available
Mounjaro, Injection, 7.5 mg/.5 mL (NDC 0002-1484-80)	Available
Mounjaro, Injection, 12.5 mg/.5 mL (NDC 0002-1460-80)	Available
Mounjaro, Injection, 15 mg/.5 mL (NDC 0002-1457-80)	Available